Hympavzi Injection, Solution
Product Images NDC 0069-1510

Product Visual Gallery

This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Hympavzi (NDC 0069-1510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – 150 mg/ml Prefilled Pen (Hympavzi 01)

This text provides information on a medication with the name HYMPAVZI™, manufactured by Pfizer Inc. It is an injection with a concentration of 150 mg/mL, intended for subcutaneous use only. The storage instructions recommend refrigeration at temperatures between 36°F to 46°F (2°C to 8°C) and emphasize protection from light while cautioning against shaking the product. Details such as recommended dosage, lot number, expiration date, and prescribing information are available for further reference.*

FDA Label Image

Principal Display Panel – 150 mg/ml Prefilled Pen Carton (Hympavzi 02)

FDA Label Image

Pfizer Logo (Marstacimab 01)

This text provides information about Pfizer, a pharmaceutical company based in New York, NY 10001. Pfizer is the manufacturer of the product mentioned in the text.*

FDA Label Image

Pfizer Logo (Marstacimab 02)

This text provides information about Pfizer Inc., a pharmaceutical company based in New York. The company manufactures products in New York, NY 10001.*

FDA Label Image

Syringe Supplies (Marstacimab 03)

This is a description of items needed for handling a HYMPAVZI Prefilled Syringe, including alcohol swab, cotton ball or gauze pad, and a sharps disposal container. These items are essential for proper injection and safe disposal of medical waste.*

FDA Label Image

Syringe Before And After (Marstacimab 04)

This text provides instructions for a HYMPAVII prefilled syringe before and after use. It includes details about the components such as barrel, needle cover, plunger rod, label, finger grip, and gray plunger stopper. The description indicates the proper setup and features of the syringe for both pre and post-use scenarios.*

FDA Label Image

Syringe Step 2 (Marstacimab 05)

FDA Label Image

Syringe Step 3 (Marstacimab 06)

FDA Label Image

Syringe Step 4 (Marstacimab 07)

This text provides instructions on how to choose and clean the injection site, mentioning specific areas like the stomach area (abdomen), upper arms, and thighs. It advises keeping a distance of at least 2 inches from the belly button when injecting into the stomach area. Additionally, it emphasizes that injections in the thigh area should be administered by a healthcare provider or caregiver.*

FDA Label Image

Syringe Step 5 (Marstacimab 08)

FDA Label Image

Syringe Step 6 (Marstacimab 09)

FDA Label Image

Syringe Step 7 (Marstacimab 10)

This text is not readable.*

FDA Label Image

Syringe Step 8 (Marstacimab 11)

FDA Label Image

Syringe Step 9 (Marstacimab 12)

FDA Label Image

Syringe Step 10 (Marstacimab 13)

This text appears to be a header or title indicating a section related to "After Care". It likely pertains to a service or system for providing support or assistance after a particular event or activity.*

FDA Label Image

Syringe Step 11 (Marstacimab 14)

This text indicates a topic related to handling or getting rid of a syringe after use. It likely refers to guidance or instructions on how to properly dispose of a syringe to ensure safety and proper waste management.*

FDA Label Image

Pfizer Logo (Marstacimab 15)

This text states that the mentioned product is manufactured by Pfizer Inc. based in New York, NY 10001.*

FDA Label Image

Pen Supplies (Marstacimab 16)

This text mentions a HYMPAVZI prefilled pen along with items such as alcohol swab, cotton ball, gauze pad, and sharps disposal container. It seems to be related to medical equipment or medications.*

FDA Label Image

Pen Before And After (Marstacimab 17)

This text appears to be instructions for using a HYMPAVZI prefilled pen. It explains to check various components before and after use, such as the needle guard, dose strength, expiration date window, and plunger. It also mentions the change in the needle guard to a locked position after use, with additional details highlighted in a yellow bar in the window.*

FDA Label Image

Pen Step 2 (Marstacimab 18)

This text appears to be a simple instruction to remind someone to check the expiration date.*

FDA Label Image

Pen Step 3 (Marstacimab 19)

FDA Label Image

Pen Step 4 (Marstacimab 20)

This text provides guidelines on choosing and cleaning the injection sites. It suggests keeping at least 2 inches away from the belly when injecting in the stomach area (abdomen) and advises that injections in the buttocks or thighs should be administered by a healthcare provider or caregiver.*

FDA Label Image

Pen Step 5 (Marstacimab 21)

FDA Label Image

Pen Step 6 (Marstacimab 22)

This text provides instructions on how to inject medicine using a device that requires firm pressure to push down and indicates a second click. The countdown towards the end suggests a step-by-step process for administering the medicine effectively.*

FDA Label Image

Pen Step 7 (Marstacimab 23)

FDA Label Image

Pen Step 8 (Marstacimab 24)

FDA Label Image

Pen Step 9 (Marstacimab 25)

FDA Label Image

Pen Step 10 (Marstacimab 26)

FDA Label Image

Pfizer Logo (Marstacimab 27)

This information pertains to a product manufactured by Pfizer Inc. located in New York, NY 10001.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.